Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India · Delayed Price · Currency is INR 8,590.30
+113.80 (1.34%)
At close: Jul 31, 2026
BOM:500459 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 42,364 | 42,816 | 43,019 | 42,057 | 39,179 | 39,009 |
Other Revenue | 85 | 88.3 | 43.2 | - | - | - |
| 42,449 | 42,904 | 43,062 | 42,057 | 39,179 | 39,009 | |
Revenue Growth | -1.54% | -0.37% | 2.39% | 7.35% | 0.43% | 9.14% |
Cost of Revenue | 16,042 | 15,652 | 16,407 | 16,292 | 16,710 | 15,675 |
Gross Profit | 26,406 | 27,253 | 26,655 | 25,765 | 22,469 | 23,335 |
Selling, General & Admin | 7,585 | 7,379 | 8,346 | 7,750 | 6,233 | 6,785 |
Other Operating Expenses | 8,072 | 8,164 | 8,165 | 7,893 | 7,469 | 8,129 |
Operating Expenses | 16,036 | 15,917 | 16,964 | 16,208 | 14,286 | 15,443 |
Operating Income | 10,370 | 11,336 | 9,691 | 9,557 | 8,183 | 7,892 |
Interest Expense | -96.5 | -94.5 | -88.6 | -202.5 | -52.6 | -59.4 |
Interest & Investment Income | - | - | 288.6 | 452.2 | 362.1 | 242.9 |
Currency Exchange Gain (Loss) | - | - | -39.1 | -37.3 | -43.7 | -70.1 |
Other Non Operating Income (Expenses) | 442.1 | 424.7 | 90.6 | 70.3 | 43.7 | 0.3 |
EBT Excluding Unusual Items | 10,716 | 11,666 | 9,942 | 9,839 | 8,493 | 8,006 |
Merger & Restructuring Charges | - | - | -32.6 | -135.6 | - | - |
Gain (Loss) on Sale of Assets | - | - | -2.3 | -55.4 | -8.3 | -17.6 |
Asset Writedown | - | - | -63 | -130.3 | - | - |
Other Unusual Items | - | - | -99.7 | -126.1 | -89.6 | -86.6 |
Pretax Income | 10,716 | 11,666 | 9,744 | 9,392 | 8,395 | 7,901 |
Income Tax Expense | 2,809 | 3,101 | 2,568 | 2,642 | 1,613 | 2,144 |
Net Income | 7,907 | 8,565 | 7,177 | 6,750 | 6,781 | 5,758 |
Net Income to Common | 7,907 | 8,565 | 7,177 | 6,750 | 6,781 | 5,758 |
Net Income Growth | -4.58% | 19.35% | 6.31% | -0.46% | 17.78% | -11.67% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change | 0.00% | -0.00% | 0.00% | - | - | - |
EPS (Basic) | 243.59 | 263.86 | 221.08 | 207.95 | 208.91 | 177.37 |
EPS (Diluted) | 243.59 | 263.86 | 221.08 | 207.95 | 208.91 | 177.37 |
EPS Growth | -4.58% | 19.35% | 6.31% | -0.46% | 17.78% | -11.67% |
Free Cash Flow | - | 8,745 | 7,176 | 4,253 | 7,813 | 5,233 |
Free Cash Flow Per Share | - | 269.42 | 221.06 | 131.03 | 240.70 | 161.21 |
Dividend Per Share | - | 230.000 | 233.333 | 195.000 | 185.000 | 160.000 |
Dividend Growth | - | -1.43% | 19.66% | 5.41% | 15.63% | -3.03% |
Gross Margin | 62.21% | 63.52% | 61.90% | 61.26% | 57.35% | 59.82% |
Operating Margin | 24.43% | 26.42% | 22.50% | 22.72% | 20.89% | 20.23% |
Profit Margin | 18.63% | 19.96% | 16.67% | 16.05% | 17.31% | 14.76% |
Free Cash Flow Margin | - | 20.38% | 16.66% | 10.11% | 19.94% | 13.41% |
EBITDA | 10,734 | 11,710 | 10,106 | 10,111 | 8,756 | 8,407 |
EBITDA Margin | 25.29% | 27.29% | 23.47% | 24.04% | 22.35% | 21.55% |
D&A For EBITDA | 364.11 | 374.3 | 415.07 | 553.8 | 572.4 | 514.9 |
EBIT | 10,370 | 11,336 | 9,691 | 9,557 | 8,183 | 7,892 |
EBIT Margin | 24.43% | 26.42% | 22.50% | 22.72% | 20.89% | 20.23% |
Effective Tax Rate | 26.21% | 26.58% | 26.35% | 28.13% | 19.22% | 27.13% |
Revenue as Reported | 42,891 | 43,329 | 43,508 | 42,580 | 39,585 | 39,252 |
Advertising Expenses | - | 5,227 | - | 5,310 | 4,084 | 4,546 |